Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven C Katz

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
The Journal of Surgical Research|December 20, 2021
Antigen Receptor T Cells (CAR-T) Effectively Control Tumor Growth in a Colorectal Liver Metastasis ModelLouis F Chai, John C Hardaway, Kara R Heatherton, et al.
Annals of Surgical Oncology|September 27, 2012
Regulatory T cell infiltration predicts outcome following resection of colorectal cancer liver metastasesSteven C Katz, Zubin M Bamboat, Ajay V Maker, et al.
Journal for Immunotherapy of Cancer|August 27, 2020
HITM-SURE: Hepatic immunotherapy for metastases phase Ib anti-CEA CAR-T study utilizing pressure enabled drug deliverySteven C Katz, Ashley E Moody, Prajna Guha, et al.
Cytokine: X|September 8, 2020
Tocilizumab for severe COVID-19 related illness - A community academic medical center experienceKapil S Meleveedu, John Miskovsky, Joseph Meharg, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 19, 2010
T cell infiltrate and outcome following resection of intermediate-grade primary neuroendocrine tumours and liver metastasesSteven C Katz, Charan Donkor, Kristen Glasgow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2015
Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor-Modified T-cell Therapy for CEA+ Liver MetastasesSteven C Katz, Rachel A Burga, Elise McCormack, et al.
Journal for Immunotherapy of Cancer|July 22, 2024
Subcutaneous checkpoint inhibition is equivalent to systemic delivery when combined with nelitolimod delivered via pressure-enabled drug delivery for depletion of intrahepatic myeloid-derived suppressor cells and control of liver metastasesChandra C Ghosh, Lauren Cournoyer, Yujia Liu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 26, 2016
Mincle Signaling Promotes Con A HepatitisStephanie H Greco, Alejandro Torres-Hernandez, Aleksandr Kalabin, et al.
Gut|June 15, 2022
Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastasesKevin M Sullivan, Xiuyun Jiang, Prajna Guha, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
The Journal of Surgical Research|December 20, 2021
Antigen Receptor T Cells (CAR-T) Effectively Control Tumor Growth in a Colorectal Liver Metastasis ModelLouis F Chai, John C Hardaway, Kara R Heatherton, et al.
Annals of Surgical Oncology|September 27, 2012
Regulatory T cell infiltration predicts outcome following resection of colorectal cancer liver metastasesSteven C Katz, Zubin M Bamboat, Ajay V Maker, et al.
Journal for Immunotherapy of Cancer|August 27, 2020
HITM-SURE: Hepatic immunotherapy for metastases phase Ib anti-CEA CAR-T study utilizing pressure enabled drug deliverySteven C Katz, Ashley E Moody, Prajna Guha, et al.
Cytokine: X|September 8, 2020
Tocilizumab for severe COVID-19 related illness - A community academic medical center experienceKapil S Meleveedu, John Miskovsky, Joseph Meharg, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 19, 2010
T cell infiltrate and outcome following resection of intermediate-grade primary neuroendocrine tumours and liver metastasesSteven C Katz, Charan Donkor, Kristen Glasgow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2015
Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor-Modified T-cell Therapy for CEA+ Liver MetastasesSteven C Katz, Rachel A Burga, Elise McCormack, et al.
Journal for Immunotherapy of Cancer|July 22, 2024
Subcutaneous checkpoint inhibition is equivalent to systemic delivery when combined with nelitolimod delivered via pressure-enabled drug delivery for depletion of intrahepatic myeloid-derived suppressor cells and control of liver metastasesChandra C Ghosh, Lauren Cournoyer, Yujia Liu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 26, 2016
Mincle Signaling Promotes Con A HepatitisStephanie H Greco, Alejandro Torres-Hernandez, Aleksandr Kalabin, et al.
Gut|June 15, 2022
Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastasesKevin M Sullivan, Xiuyun Jiang, Prajna Guha, et al.
Pageof 8